| David Curt Chaffin, MD | |
|
1720 Gunbarrel Rd, Suite 400, Chattanooga, TN 37421-3192 | |
| (423) 499-4100 | |
| (423) 499-1945 |
| Full Name | David Curt Chaffin |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 27 Years |
| Location | 1720 Gunbarrel Rd, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235178377 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Galen Medical Group, Pc | 2668377391 | 126 |
| Galen Medical Group, Pc | 2668377391 | 126 |
News Archive
Local scientists, health advocates and leaders from the California Institute for Regenerative Medicine will gather in San Diego June 23 for a special public meeting to spotlight a new University of California, San Diego grant to pursue novel, fast-tracked stem cell-based therapies for amyotrophic lateral sclerosis, or Lou Gehrig's disease.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH. The publication, which is authored by PROLOR researchers, will also be included in the September print edition of Endocrinology.
A nanoparticle drug-delivery system that combines two complementary types of anticancer treatment could improve outcomes for patients with pancreatic cancer and other highly treatment-resistant tumors while decreasing toxicity.
Anadys Pharmaceuticals, Inc. announced today that 72% of hepatitis C patients receiving ANA598 400 mg twice daily (bid) plus standard of care achieved undetectable levels of virus at week eight in an ongoing Phase II study, compared to 38% of patients receiving placebo plus SOC.
› Verified 4 days ago
| Entity Name | Galen Medical Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346250057 PECOS PAC ID: 2668377391 Enrollment ID: O20031204001027 |
News Archive
Local scientists, health advocates and leaders from the California Institute for Regenerative Medicine will gather in San Diego June 23 for a special public meeting to spotlight a new University of California, San Diego grant to pursue novel, fast-tracked stem cell-based therapies for amyotrophic lateral sclerosis, or Lou Gehrig's disease.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH. The publication, which is authored by PROLOR researchers, will also be included in the September print edition of Endocrinology.
A nanoparticle drug-delivery system that combines two complementary types of anticancer treatment could improve outcomes for patients with pancreatic cancer and other highly treatment-resistant tumors while decreasing toxicity.
Anadys Pharmaceuticals, Inc. announced today that 72% of hepatitis C patients receiving ANA598 400 mg twice daily (bid) plus standard of care achieved undetectable levels of virus at week eight in an ongoing Phase II study, compared to 38% of patients receiving placebo plus SOC.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Curt Chaffin, MD 4976 Alpha Ln, Hixson, TN 37343-5470 Ph: (423) 497-5355 | David Curt Chaffin, MD 1720 Gunbarrel Rd, Suite 400, Chattanooga, TN 37421-3192 Ph: (423) 499-4100 |
News Archive
Local scientists, health advocates and leaders from the California Institute for Regenerative Medicine will gather in San Diego June 23 for a special public meeting to spotlight a new University of California, San Diego grant to pursue novel, fast-tracked stem cell-based therapies for amyotrophic lateral sclerosis, or Lou Gehrig's disease.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH. The publication, which is authored by PROLOR researchers, will also be included in the September print edition of Endocrinology.
A nanoparticle drug-delivery system that combines two complementary types of anticancer treatment could improve outcomes for patients with pancreatic cancer and other highly treatment-resistant tumors while decreasing toxicity.
Anadys Pharmaceuticals, Inc. announced today that 72% of hepatitis C patients receiving ANA598 400 mg twice daily (bid) plus standard of care achieved undetectable levels of virus at week eight in an ongoing Phase II study, compared to 38% of patients receiving placebo plus SOC.
› Verified 4 days ago
Susan P Raschal, D.O. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1350 Mackey Branch Dr, Suite 114, Chattanooga, TN 37421 Phone: 423-468-3267 Fax: 423-468-3270 | |
Marc William Cromie Sr., M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 6734 Lee Hwy, Chattanooga, TN 37421 Phone: 423-899-0431 Fax: 423-499-9552 | |
Michael C Hollie, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1720 Gunbarrel Rd, Suite 400, Chattanooga, TN 37421 Phone: 423-499-4100 Fax: 423-499-1945 | |
Jennifer King Patel, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 6734 Lee Hwy, Chattanooga, TN 37421 Phone: 423-899-0431 Fax: 423-499-9552 | |
Hyman Moses Kaplan, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 6734 Lee Hwy, Chattanooga, TN 37421 Phone: 423-899-0431 Fax: 423-499-9552 | |
Dr. Joseph Marion Wisniewski, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1350 Mackey Branch Dr, Ste 114, Chattanooga, TN 37421 Phone: 423-468-3267 Fax: 423-468-3270 |